Rapamycin nanoparticle (3sBio)

雷帕霉素纳米粒 (3sBio)

Report date: 2026/03/04 20:01:44
NME

Base Information

Drug NameRapamycin nanoparticle (3sBio)
Drug Alias NameSSS-39SSS39
ClassificationSmall molecules > Heterocyclic drugsSmall molecules > Molecular Glue
Mechanisms of ActionmTOR Complex 2 inhibitorsMammalian target of Rapamycin (mTORC1) inhibitors
TargetsmTOR Complex 2Mammalian target of Rapamycin (mTORC1)
Therapy Area/IndicationsAutoimmune Diseases
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaPhase 1 Clinical
Originator Companies3sbio Inc
China Registration ClassClass 1 Chemical Drug in China

Develop Information

Active Companies3sbio IncShenyang Sunshine Pharmaceutical Co Ltd
Inactive CompaniesN/A
Active IndicationsAutoimmune Diseases
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A